期刊文献+

庆大霉素-壳聚糖纳米涂层钛板的制备及系列研究 被引量:1

Preparation and series studies of the gentamicin sulfate/chitosan nanospheres loaded plates
下载PDF
导出
摘要 目的:制备负载庆大霉素-壳聚糖纳米粒的涂层钛板并对其表面形态、体外释药行为及抗金黄色葡萄球菌的性能进行评价。方法:采用溶剂铸膜(solvent casting)法制备庆大霉素-壳聚糖纳米涂层钛板,扫描电镜观察其表面形态,磷酸盐缓冲液中研究其体外释药行为,将庆大霉素-壳聚糖纳米涂层钛板置于均匀涂有1×108 CFU/ml金黄色葡萄球菌的Mueller-Hinton(MH)平板上连续培养直至抑菌环消失,以抑菌环直径为主要观察指标评价其在体外对金黄色葡萄球菌的抑制作用。结果:扫描电镜示庆大霉素-壳聚糖纳米粒较均匀地分布于钛板表面;体外释药行为显示庆大霉素-壳聚糖纳米涂层钛板中庆大霉素的释放可达到14 d,维持在52%左右;体外抑制金黄色葡萄球菌作用可维持9 d,抑菌环最大直径为(3.82±0.03)cm。结论:制备的庆大霉素-壳聚糖纳米涂层钛板表面形态良好,体外释药稳定,对金黄色葡萄球菌有良好的抑制作用。 Objective: To develop the gentamicin sulfate/chitosan nanospheres loaded plates and evaluate its characteristics such as surface structure and the drug release behavior of the drug in vitro and its anti-Staph aureus efficacy in vitro.Methods: The solvent casting technology was adopted to prepare the gentamicin sulfate/chitosan nanospheres loaded plates.The surface appearance of the plates was observed by SEM,the drug release behavior in vitro was studied by immerse the plates into PBS.And the gentamicin sulfate/chitosan nanospheres loaded plates were placed in the centre of the Mueller-Hinton(MH) agar which were inoculated with the Staph aureus at the concentration of 1 × 108 CFU/ml.The bacteria were cultured on MH agar for 48 h and the diameter of the inhibition zone was measured,and this procedure was repeated until there was no inhibition zone.Result: The result of the SEM shows the gentamicin sulfate/chitosan nanospheres distributed on the surface of plates uniform,the drug release behavior in vitro could continue about 14 days,and the max cumulative release of the drug was about 52%.The anti-Staph aureus efficacy in vitro could continue about 9 days and the max diameter of the inhibition zone was(3.82 ± 0.03) cm.Conclusion: The gentamicin sulfate/chitosan nanospheres loaded plates show well surface appearance and the plates have a steady drug release behavior and significant anti-Staph aureus efficacy in vitro.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第11期1690-1694,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家重点基础研究发展计划(973计划)子课题(2007CB936100)
关键词 硫酸庆大霉素 壳聚糖 聚消旋乳酸 纳米粒 金黄色葡萄球菌 gentamicins chitosan PDLLA nanospheres Staphylococcus aureus
  • 相关文献

参考文献23

  • 1Berend KR,Sporer SM,Sierra RJ,et al. Achieving stability and lower limb length in total hip arthroplasty[J]. Instr Course Lect,2011,60:229-246.
  • 2Ercan B,Kummer KM,Tarquinio KM,et al. Decreased Staphylococcus aureus biofilm growth on anodized nan- otubular titanium and the effect of electrical stimulation [J]. Acta Biomater,2011,7(7) :3003-3012.
  • 3Vester H,Wildemann B,Schmidmaier G,et al. Gentamycin delivered from a PDLLA coating of metallic im- plants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis [J]. Injury, 2010,41 (10) : 1053-1059.
  • 4Darouiche RO. Treatment of infections associated with surgical implants [J]. N Engl J Med,2004,350(14): 1422-1429.
  • 5Naraharisetti PK,Lew MD,Fu YC,et al. Gentamicin-loaded discs and microspheres and their modifications:characterization and in vitro release [J]. J Control Release, 2005,102(2) :345-359.
  • 6Viguier E,Bignon A,Laurent F,et al. A new concept of gentamicin loaded HAP/TCP bone substitute for prophy- lactic action:in vivo pharmacokinetic study [J]. J Mater Sci Mater Med, 2011,22(4) : 879-886.
  • 7Gollwitzer H,Ibrahim K,Meyer H,et al. Antibacterial poly (D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology [J]. J Antimicrob Chemother, 2003,51 (3) : 585-591.
  • 8Lucke M,Schmidmaier G,Sadoni S,et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats[J]. Bone,2003,32(5):521-531.
  • 9Schmidmaier G,Wildemann B, Stemberger A,et al. Biodegradable poly (D,L-lactide) coating of implants for continuous release of growth factors [J]. J Biomed Mater Res, 2001,58(4) :449-455.
  • 10季金苟,李红,董瑾,郝石磊,吴丹君,夏之宁.硫酸庆大霉素/壳聚糖纳米球的制备及其释药性能[J].中国抗生素杂志,2010,35(10):767-770. 被引量:6

二级参考文献60

  • 1李秋霞,赵品花,姜明堂.静脉滴注硫酸庆大霉素致过敏死亡5例[J].中国药事,2005,19(2):122-123. 被引量:3
  • 2Storm G,Belliot S O,Daemen T,et al.Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system[J].Adv Drug Deliv Rev,1995,17:31-48.
  • 3Mitra S,Gaur U,Gosh P C,et al.Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier[J].J Control Release,2001,74:317-323.
  • 4Nishioka Y,Yoshino H.Lymphatic targeting with nanoparticulate system[J].Adv Drug Deliv Rev,2001,47:55-64.
  • 5Xu Y M,Du Y M.Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles[J].Int J Pharm,2003,250:215-226.
  • 6Gan Q,Wang T.Chitosan nanoparticle as protein delivery carrier-Systematic examination of fabrication conditions for efficient loading and release[J].Coll Surf B,2007,59:24-34.
  • 7Shu X Z,Zhu K J.The influence of multivalent phosphate structure on the properties of ionieally cross-linked chitosan films for controlled drug release[J].Eur J Ph B,2002,54:235-243.
  • 8Azzam K, Parvizi J, Jungkind D, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg (Am), 2009, 91 Suppl 6: 142-149.
  • 9Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med, 2004, 351(16): 1645-1654.
  • 10Marculescu CE, Berbari EF, Cockerill FR 3rd, et al. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res, 2006, (451): 64-72.

共引文献7

同被引文献19

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部